Funding Rounds
Artios Pharma

Artios Pharma Series C (2021, $152M)

Artios Pharma

Independent biotech company focused on developing new cancer therapies targeting DNA damage response.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $152.70M

Raised Date: 2021-01-01